Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Helse Vest | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to examine the content of the treatment being delivered for anxiety disorders for children and adolescents in the regular outpatient clinics in western Norway. The study will also collect data before and after treatment to evaluate the result of the treatment. Furthermore, as part of the study we aim to collect normative data on two questionnaires used to identify anxiety symptoms and the extent to which anxiety interfere with daily functioning. We also aim to develop a quality indicator for anxiety treatment that can be used to monitor treatment in the regular outpatient service, based on the results of the current study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Psychosocial treatment | Children and adolescents with anxiety disorders |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Psychosocial treatment | Other | Regular psychosocial treatment in clinical outpatient service. |
|
| Measure | Description | Time Frame |
|---|---|---|
| The Anxiety Disorder Interview Schedule for Diagnostic and Statistical Manual (DSM-IV), child and parent versions (ADIS- C/P; Silverman & Albano, 1996). | Diagnostic interview for anxiety disorders and other comorbid disorders. For the 10-year follow-up we anticipate to use another version of the diagnostic interview schedule based on revised diagnostic criteria for anxiety disorders. | The primary outcome measure will be administered pre-treatment, post treatment (an expected average of 20 weeks) and at ten year follow-up. |
| Measure | Description | Time Frame |
|---|---|---|
| Children's Anxiety Life Interference Scale (CALIS; Lyneham et al., 2013) | This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks). | |
| The Screen for Child Anxiety Related Emotional Disorders (SCARED; Birmaher et al., 1999). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Children/adolescents from 7-17 years old referred to ordinary outpatient mental health service.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jon F Bjaastad, D. Psych | Division of Psychiatry, Stavanger University Hospital, N-4068 Stavanger, Norway | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| BUPA Helse Stavanger | Stavanger | Rogaland | 4011 | Norway |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001008 | Anxiety Disorders |
| ID | Term |
|---|---|
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
| This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks). |
| Spence Children's Anxiety Scale (SCAS; Spence, 1998) | This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks). |
| The Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997) | This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks) |
| Short Mood & Feeling Questionaire (SMFQ; Angold et al., 1995). | This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks) |
| Clinical Global Impressions (CGI; Guy, 1976). | The outcome measure will be administered pre-treatment, post treatment (an expected average of 20 weeks) and at ten year follow-up. |